The recent surge in capital into boutique pharmaceutical companies, particularly those focusing on experimental therapies and difficult drug development programs, has fueled what some are calling "High Roller Pharma." https://majavfnl596262.suomiblog.com/high-investor-pharma-a-speculative-wager-55912647